SENTINELONE INC -CLASS A (1SUS.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:1SUS • US81730H1095

10.8 EUR
-2.2 (-16.92%)
Last: Feb 9, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to 1SUS. 1SUS was compared to 122 industry peers in the Software industry. While 1SUS seems to be doing ok healthwise, there are quite some concerns on its profitability. 1SUS shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • 1SUS had positive earnings in the past year.
  • In the past year 1SUS had a positive cash flow from operations.
  • In the past 5 years 1SUS always reported negative net income.
  • In the past 5 years 1SUS reported 4 times negative operating cash flow.
1SUS.MI Yearly Net Income VS EBIT VS OCF VS FCF1SUS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M

1.2 Ratios

  • 1SUS has a worse Return On Assets (-16.91%) than 83.19% of its industry peers.
  • With a Return On Equity value of -26.54%, 1SUS is not doing good in the industry: 79.83% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -16.91%
ROE -26.54%
ROIC N/A
ROA(3y)-14.45%
ROA(5y)-15.84%
ROE(3y)-20.46%
ROE(5y)-23.39%
ROIC(3y)N/A
ROIC(5y)N/A
1SUS.MI Yearly ROA, ROE, ROIC1SUS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 100 -100 200 300

1.3 Margins

  • 1SUS has a Gross Margin of 74.69%. This is comparable to the rest of the industry: 1SUS outperforms 52.94% of its industry peers.
  • 1SUS's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for 1SUS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y4.22%
1SUS.MI Yearly Profit, Operating, Gross Margins1SUS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • 1SUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for 1SUS has been increased compared to 1 year ago.
  • The number of shares outstanding for 1SUS has been increased compared to 5 years ago.
  • There is no outstanding debt for 1SUS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1SUS.MI Yearly Shares Outstanding1SUS.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 100M 200M 300M
1SUS.MI Yearly Total Debt VS Total Assets1SUS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • 1SUS has an Altman-Z score of 2.36. This is not the best score and indicates that 1SUS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • 1SUS has a Altman-Z score (2.36) which is comparable to the rest of the industry.
  • There is no outstanding debt for 1SUS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.36
ROIC/WACCN/A
WACC11.1%
1SUS.MI Yearly LT Debt VS Equity VS FCF1SUS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.52 indicates that 1SUS should not have too much problems paying its short term obligations.
  • 1SUS has a Current ratio of 1.52. This is comparable to the rest of the industry: 1SUS outperforms 54.62% of its industry peers.
  • A Quick Ratio of 1.52 indicates that 1SUS should not have too much problems paying its short term obligations.
  • 1SUS's Quick ratio of 1.52 is in line compared to the rest of the industry. 1SUS outperforms 57.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.52
1SUS.MI Yearly Current Assets VS Current Liabilites1SUS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 1800.00% over the past year.
  • Looking at the last year, 1SUS shows a very strong growth in Revenue. The Revenue has grown by 24.09%.
  • The Revenue has been growing by 77.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1800%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.7%
Revenue 1Y (TTM)24.09%
Revenue growth 3Y58.89%
Revenue growth 5Y77.59%
Sales Q2Q%22.91%

3.2 Future

  • 1SUS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 75.02% yearly.
  • The Revenue is expected to grow by 20.85% on average over the next years. This is a very strong growth
EPS Next Y289.07%
EPS Next 2Y148.24%
EPS Next 3Y106.38%
EPS Next 5Y75.02%
Revenue Next Year22.54%
Revenue Next 2Y21.29%
Revenue Next 3Y19.9%
Revenue Next 5Y20.85%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
1SUS.MI Yearly Revenue VS Estimates1SUS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 1B 2B 3B
1SUS.MI Yearly EPS VS Estimates1SUS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 77.14, the valuation of 1SUS can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1SUS is on the same level as its industry peers.
  • 1SUS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.03.
  • The Price/Forward Earnings ratio is 41.16, which means the current valuation is very expensive for 1SUS.
  • 1SUS's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.97, 1SUS is valued a bit more expensive.
Industry RankSector Rank
PE 77.14
Fwd PE 41.16
1SUS.MI Price Earnings VS Forward Price Earnings1SUS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 1SUS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 94.16
EV/EBITDA N/A
1SUS.MI Per share data1SUS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 1SUS's earnings are expected to grow with 106.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.27
PEG (5Y)N/A
EPS Next 2Y148.24%
EPS Next 3Y106.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • 1SUS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SENTINELONE INC -CLASS A

BIT:1SUS (2/9/2026, 7:00:00 PM)

10.8

-2.2 (-16.92%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-04
Earnings (Next)03-10
Inst Owners74.23%
Inst Owner ChangeN/A
Ins Owners0.7%
Ins Owner ChangeN/A
Market Cap3.62B
Revenue(TTM)955.65M
Net Income(TTM)-411.29M
Analysts78.18
Price Target18.72 (73.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.2%
Min EPS beat(2)29.34%
Max EPS beat(2)37.07%
EPS beat(4)4
Avg EPS beat(4)66.06%
Min EPS beat(4)23.01%
Max EPS beat(4)174.81%
EPS beat(8)7
Avg EPS beat(8)80.73%
EPS beat(12)11
Avg EPS beat(12)65.4%
EPS beat(16)15
Avg EPS beat(16)53.64%
Revenue beat(2)0
Avg Revenue beat(2)-1.73%
Min Revenue beat(2)-1.95%
Max Revenue beat(2)-1.5%
Revenue beat(4)0
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-1.95%
Max Revenue beat(4)-0.52%
Revenue beat(8)2
Avg Revenue beat(8)-0.85%
Revenue beat(12)4
Avg Revenue beat(12)-0.41%
Revenue beat(16)8
Avg Revenue beat(16)0.68%
PT rev (1m)-11.62%
PT rev (3m)N/A
EPS NQ rev (1m)-18.79%
EPS NQ rev (3m)-18.71%
EPS NY rev (1m)2.48%
EPS NY rev (3m)2.57%
Revenue NQ rev (1m)-0.7%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE 77.14
Fwd PE 41.16
P/S 4.45
P/FCF 94.16
P/OCF 61.74
P/B 2.74
P/tB 8.54
EV/EBITDA N/A
EPS(TTM)0.14
EY1.3%
EPS(NY)0.26
Fwd EY2.43%
FCF(TTM)0.11
FCFY1.06%
OCF(TTM)0.17
OCFY1.62%
SpS2.43
BVpS3.94
TBVpS1.26
PEG (NY)0.27
PEG (5Y)N/A
Graham Number3.52
Profitability
Industry RankSector Rank
ROA -16.91%
ROE -26.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.69%
FCFM 4.72%
ROA(3y)-14.45%
ROA(5y)-15.84%
ROE(3y)-20.46%
ROE(5y)-23.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y4.22%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 48.39%
Cap/Sales 2.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.52
Quick Ratio 1.52
Altman-Z 2.36
F-Score6
WACC11.1%
ROIC/WACCN/A
Cap/Depr(3y)58.32%
Cap/Depr(5y)105.17%
Cap/Sales(3y)3.59%
Cap/Sales(5y)4.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1800%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.7%
EPS Next Y289.07%
EPS Next 2Y148.24%
EPS Next 3Y106.38%
EPS Next 5Y75.02%
Revenue 1Y (TTM)24.09%
Revenue growth 3Y58.89%
Revenue growth 5Y77.59%
Sales Q2Q%22.91%
Revenue Next Year22.54%
Revenue Next 2Y21.29%
Revenue Next 3Y19.9%
Revenue Next 5Y20.85%
EBIT growth 1Y5.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year336.9%
EBIT Next 3Y92.12%
EBIT Next 5YN/A
FCF growth 1Y144.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y181.7%
OCF growth 3YN/A
OCF growth 5YN/A

SENTINELONE INC -CLASS A / 1SUS.MI FAQ

Can you provide the ChartMill fundamental rating for SENTINELONE INC -CLASS A?

ChartMill assigns a fundamental rating of 4 / 10 to 1SUS.MI.


Can you provide the valuation status for SENTINELONE INC -CLASS A?

ChartMill assigns a valuation rating of 3 / 10 to SENTINELONE INC -CLASS A (1SUS.MI). This can be considered as Overvalued.


How profitable is SENTINELONE INC -CLASS A (1SUS.MI) stock?

SENTINELONE INC -CLASS A (1SUS.MI) has a profitability rating of 1 / 10.


What is the valuation of SENTINELONE INC -CLASS A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SENTINELONE INC -CLASS A (1SUS.MI) is 77.14 and the Price/Book (PB) ratio is 2.74.